EP2725028A1 — Substituted pyrazolo[1,5-]pyrimidine compounds as intermediates in the synthesis of TRK kinase inhibitors
Assigned to Array Biopharma Inc · Expires 2014-04-30 · 12y expired
What this patent protects
A compound selected from the group consisting of: - a compound of formula: or a pharmaceutically acceptable salt thereof, and - a compound of formula: or a pharmaceutically acceptable salt thereof.
USPTO Abstract
A compound selected from the group consisting of: - a compound of formula: or a pharmaceutically acceptable salt thereof, and - a compound of formula: or a pharmaceutically acceptable salt thereof.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.